120 related articles for article (PubMed ID: 15571779)
1. A sensitive and specific HPLC method for the determination of total pentosidine concentration in plasma.
Słowik-Zyłka D; Safranow K; Dziedziejko V; Bukowska H; Ciechanowski K; Chlubek D
J Biochem Biophys Methods; 2004 Nov; 61(3):313-29. PubMed ID: 15571779
[TBL] [Abstract][Full Text] [Related]
2. Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection.
Scheijen JL; van de Waarenburg MP; Stehouwer CD; Schalkwijk CG
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(7):610-4. PubMed ID: 19188098
[TBL] [Abstract][Full Text] [Related]
3. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients.
Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D
J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428
[TBL] [Abstract][Full Text] [Related]
4. Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure.
Sanaka T; Funaki T; Tanaka T; Hoshi S; Niwayama J; Taitoh T; Nishimura H; Higuchi C
Nephron; 2002 May; 91(1):64-73. PubMed ID: 12021521
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
[TBL] [Abstract][Full Text] [Related]
6. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
[TBL] [Abstract][Full Text] [Related]
7. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".
Izuhara Y; Miyata T; Saito K; Ishikawa N; Kakuta T; Nangaku M; Yoshida H; Saito A; Kurokawa K; van Ypersele de Strihou C
Am J Kidney Dis; 2004 Jun; 43(6):1024-9. PubMed ID: 15168382
[TBL] [Abstract][Full Text] [Related]
8. Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis.
Odetti P; Monacelli F; Storace D; Robaudo C; Rossi S; Deferrari G; Barreca T
Horm Metab Res; 2006 Dec; 38(12):817-20. PubMed ID: 17163357
[TBL] [Abstract][Full Text] [Related]
9. The advanced glycation endproduct pentosidine and monocyte activation in uremia.
Friedlander MA; Witko-Sarsat V; Nguyen AT; Wu YC; Labrunte M; Verger C; Jungers P; Descamps-Latscha B
Clin Nephrol; 1996 Jun; 45(6):379-82. PubMed ID: 8793229
[TBL] [Abstract][Full Text] [Related]
10. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
[TBL] [Abstract][Full Text] [Related]
11. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
Miyazaki K; Nagai R; Horiuchi S
J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
[TBL] [Abstract][Full Text] [Related]
12. [Reduction of carbonyl stress with renal replacement therapy in chronic renal failure].
Słowik-Zyłka D
Ann Acad Med Stetin; 2004; 50(2):5-15. PubMed ID: 16529161
[TBL] [Abstract][Full Text] [Related]
13. Direct quantification of pentosidine in urine and serum by HPLC with column switching.
Takahashi M; Hoshino H; Kushida K; Kawana K; Inoue T
Clin Chem; 1996 Sep; 42(9):1439-44. PubMed ID: 8787701
[TBL] [Abstract][Full Text] [Related]
14. Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography.
Floridi A; Trizza V; Paolotti P; Lucarelli C
J Chromatogr A; 1999 Jun; 846(1-2):65-71. PubMed ID: 10420599
[TBL] [Abstract][Full Text] [Related]
15. High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure.
Koyama Y; Takeishi Y; Arimoto T; Niizeki T; Shishido T; Takahashi H; Nozaki N; Hirono O; Tsunoda Y; Nitobe J; Watanabe T; Kubota I
J Card Fail; 2007 Apr; 13(3):199-206. PubMed ID: 17448417
[TBL] [Abstract][Full Text] [Related]
16. The effect of dialysis membrane type on plasma concentrations of pentosidine, a marker of carbonyl stress, in hemodialyzed patients.
Słowik-Zyłka D; Safranow K; Dziedziejko V; Ciechanowski K; Dziewanowski K; Chlubek D
Pol Arch Med Wewn; 2009 Oct; 119(10):614-20. PubMed ID: 19847136
[TBL] [Abstract][Full Text] [Related]
17. Association of serum pentosidine with arterial stiffness in hemodialysis patients.
Zhou Y; Yu Z; Jia H; Sun F; Ma L; Guo R; Peng L; Cui T
Artif Organs; 2010 Mar; 34(3):193-9. PubMed ID: 20447043
[TBL] [Abstract][Full Text] [Related]
18. A sensitive and specific ELISA for plasma pentosidine.
Izuhara Y; Miyata T; Ueda Y; Suzuki D; Asahi K; Inagi R; Sakai H; Kurokawa K
Nephrol Dial Transplant; 1999 Mar; 14(3):576-80. PubMed ID: 10193802
[TBL] [Abstract][Full Text] [Related]
19. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress".
Jadoul M; Ueda Y; Yasuda Y; Saito A; Robert A; Ishida N; Kurokawa K; Van Ypersele De Strihou C; Miyata T
Kidney Int; 1999 Jun; 55(6):2487-92. PubMed ID: 10354298
[TBL] [Abstract][Full Text] [Related]
20. Association between pentosidine and arteriosclerosis in patients receiving hemodialysis.
Kitauchi T; Yoshida K; Yoneda T; Saka T; Yoshikawa M; Ozono S; Hirao Y
Clin Exp Nephrol; 2004 Mar; 8(1):48-53. PubMed ID: 15067516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
